Advanced heart, kidney and metabolic disease linked to higher cancer risk
People with advanced heart, kidney and metabolic disease may face a higher risk of developing cancer, according to…
A little-understood sleep disorder affects millions and has clear links to dementia – 4 questions answered
A little-known and poorly understood sleep disorder that occurs during the rapid eye movement, or REM, stage of…
Patients who stop GLP-1 drugs often restart or try alternatives
A large real-world study shows that patients who stop popular GLP-1–based weight-loss drugs often return to treatment or…
Most Insomnia Meds Don’t Worsen Sleep Apnea
Summary: Treating insomnia when a patient also has Obstructive Sleep Apnea (OSA)—a condition known as COMISA—is a delicate…
How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?
A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, delivering powerful…
Tirzepatide shows dual benefits in sleep apnea trial improving metabolism and reducing inflammation
New clinical trial evidence suggests targeting both obesity and sleep-disordered breathing together may reshape cardiometabolic risk management in…
New review reveals microbiome clues to insomnia and apnea
Trillions of gut microbes may hold the key to better rest. A new review reveals how shifts in…